Related Experiment Video
Updated: Feb 21, 2026
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
Omics AnalySIs System for PRecision Oncology (OASISPRO): a web-based omics analysis tool for clinical phenotype
Kun-Hsing Yu1,2,3, Michael R Fitzpatrick4, Luke Pappas4
1Biomedical Informatics Program, Stanford University, Stanford, CA, USA.
Bioinformatics (Oxford, England)
|October 3, 2017
Summary
A new web tool, OASISPRO, helps analyze cancer omics data to predict patient outcomes. This system aids researchers in precision oncology by linking genetic information to clinical traits for personalized cancer treatments.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Precision oncology leverages individual differences for cancer management.
- Omics signatures can predict clinical traits in cancer patients.
- Analyzing vast omics data presents informatics challenges for pattern identification.
Purpose of the Study:
- To develop a user-friendly tool for mining quantitative omics data.
- To bridge the gap in data mining accessibility for non-expert users.
- To facilitate omics studies in precision cancer medicine.
Main Methods:
- Developed the Omics AnalySIs System for PRecision Oncology (OASISPRO).
- OASISPRO is a web-based system utilizing The Cancer Genome Atlas (TCGA) data.
- Implemented machine-learning algorithms for omics data analysis and prediction evaluation.
Main Results:
- Successfully identified genes associated with tumor stage.
- Accurately predicted patient survival outcomes across multiple cancer types.
- Demonstrated effectiveness in adrenocortical carcinoma analysis.
Conclusions:
- OASISPRO facilitates the identification of links between omics and clinical phenotypes.
- The system supports personalized cancer treatment plan development.
- OASISPRO enhances omics research in precision oncology.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:29Pharmacogenomics: Identification of New Drug Targets
29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793